| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |